(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COMBINO PHARM

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

COMBINO PHARM

ST13

US500000097401037

Class

5

Filing

97401037

Registration

7186360

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

11/01/2023

Trademark type

Combined

Nice classes

5

Filing date

05/09/2022

Registration date

10/10/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/10/2023

Last transaction

10/10/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

SANT JOAN DESPI, BARCELONA, ES

Examiner

TOOLEY, DAVID E

Law office

N70

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of a white flask within a blue diamond, with the words "Combino Pharm" in blue to the right.

Holders and representatives

Holders

MEDICHEM S.A.
C. S. (pessoa física)

Representatives

Ben Natter Haug Partners, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticalveterinary and sanitary preparations for pharmaceutical or medical purposes for treatment and prevention of infections and infectious diseasesantineoplastic preparations for the treatment of cancer diseasesof disorders in coagulation and drugs for the treatment of disorders in blood cell formationcardiovascular conditions and diseasesreversal of neuromuscular blockade in anesthesiaconditions affecting the genitourinary systemmusculo-skeletal system conditionsskin and mucous membraneantidiabetic preparationsantiglaucoma preparationsanti-inflammatoriesautoimmune diseasesamyotrophic lateral sclerosis diseaserespiratory diseasessmoking cessationcalcium homeostasis/antiparathyroid agentsopioid withdrawal and Parkinson; dietetic foods adapted for medical use; food for babies; medical plasters; medical dressings; material for stopping teethdental wax; disinfectants for hygienic use; preparations for destroying vermin; fungicides; herbicides

Publications

History of USPTO decisions and trademark events.

17 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/01/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/10/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/10/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/25/2023

PUBO

PUBLISHED FOR OPPOSITION

07/25/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/05/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/21/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/25/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/25/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/25/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/23/2023

GNRT

NON-FINAL ACTION E-MAILED

03/23/2023

CNRT

NON-FINAL ACTION WRITTEN

03/23/2023

DOCK

ASSIGNED TO EXAMINER

02/27/2023

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/14/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/13/2022

NWAP

NEW APPLICATION ENTERED

05/12/2022

Continuous trademark protection

Get notified about every new filing that threatens COMBINO PHARM or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.